NEOGEN — Neogen Chemicals Balance Sheet
0.000.00%
- IN₹46.20bn
- IN₹57.23bn
- IN₹8.62bn
Annual balance sheet for Neogen Chemicals, fiscal year end - March 31st, INR millions except per share, conversion factor applied.
2022 March 31st | 2023 March 31st | 2024 March 31st | 2025 March 31st | 2026 March 31st | |
|---|---|---|---|---|---|
| Period Length: | — | — | — | — | — |
| Source: | ARS | ARS | ARS | ARS | PRESS |
| Standards: | IAS | IAS | IAS | IAS | — |
| Status: | Final | Final | Final | Final | Final |
| Cash | |||||
| Short Term Investments | |||||
| Cash and Short Term Investments | 1,136 | 948 | 125 | 49.7 | 2,912 |
| Net Total Accounts Receivable | |||||
| Net Total Receivables | 1,589 | 2,327 | 3,779 | 6,430 | 3,807 |
| Total Inventory | |||||
| Prepaid Expenses | |||||
| Total Other Current Assets | |||||
| Total Current Assets | 4,925 | 6,558 | 7,837 | 9,998 | 13,925 |
| Gross Property, Plant And Equipment | |||||
| Accumulated Depreciation | |||||
| Net Property, Plant And Equipment | 2,956 | 3,819 | 6,034 | 5,591 | 13,313 |
| Net Intangible Assets | |||||
| Long Term Investments | |||||
| Long Term Notes Receivable | |||||
| Other Long Term Assets | |||||
| Total Assets | 7,993 | 10,538 | 14,614 | 17,473 | 29,019 |
| Accounts Payable | |||||
| Accrued Expenses | |||||
| Notes Payable / Short Term Debt | |||||
| Current Portion of Long Term Debt / Capital Leases | |||||
| Total Other Current Liabilities | |||||
| Total Current Liabilities | 2,181 | 4,097 | 5,270 | 7,334 | 11,877 |
| Long Term Debt | |||||
| Capital Lease Obligations | |||||
| Total Long Term Debt | |||||
| Total Debt | |||||
| Deferred Income Tax | |||||
| Total Other Liabilities | |||||
| Total Funded Status | |||||
| Total Liabilities | 3,600 | 5,713 | 7,011 | 9,579 | 20,856 |
| Common Stock | |||||
| Additional Paid In Capital | |||||
| Retained Earnings (Accumulated Deficit) | |||||
| Other Equity | |||||
| Total Equity | 4,392 | 4,825 | 7,603 | 7,894 | 8,163 |
| Total Liabilities & Shareholders' Equity | 7,993 | 10,538 | 14,614 | 17,473 | 29,019 |
| Total Common Shares Outstanding |